The independent safety review of seven probiotic strains demonstrates to consumers that the probiotics were vetted through studies and expert panel consensus.
This confirmation expands upon the FDA's previous No Objection Letters for Nascent's Reb A to now include all steviol glycosides extracted from the leaf.
Formulation is part of the Floradapt portfolio, which are products based on a mechanistic approach to identify optimal strains for specific health applications.